| MANAGEMENT (CONT) |
|
|
|
|
|
|
|
|
|
|
| • | Proton
pump inhibitors |
||||||||
| – | daily
dosing |
||||||||
| – | documented
improved efficacy over H-RA |
||||||||
| blockers |
|||||||||
| • | Prostagladin
therapy - misoprostol |
||||||||
| – | use
with individuals who cannot d/c NSAIDs |
||||||||